These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26078752)

  • 41. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.
    Bourdenx M; Dovero S; Engeln M; Bido S; Bastide MF; Dutheil N; Vollenweider I; Baud L; Piron C; Grouthier V; Boraud T; Porras G; Li Q; Baekelandt V; Scheller D; Michel A; Fernagut PO; Georges F; Courtine G; Bezard E; Dehay B
    Acta Neuropathol Commun; 2015 Jul; 3():46. PubMed ID: 26205255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
    Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
    BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enteric Pathologic Manifestations of Alpha-Synucleinopathies.
    Punsoni M; Friedman JH; Resnick M; Donahue JE; Yang DF; Stopa EG
    Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):543-548. PubMed ID: 29189256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings.
    Adler CH; Dugger BN; Hentz JG; Hinni ML; Lott DG; Driver-Dunckley E; Mehta S; Serrano G; Sue LI; Duffy A; Intorcia A; Filon J; Pullen J; Walker DG; Beach TG
    Mov Disord; 2016 Feb; 31(2):250-6. PubMed ID: 26799362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy.
    Fernández-Valle T; Gabilondo I; Gómez-Esteban JC
    Int Rev Neurobiol; 2019; 146():281-295. PubMed ID: 31349931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature.
    Simonsen AH; Kuiperij B; El-Agnaf OM; Engelborghs S; Herukka SK; Parnetti L; Rektorova I; Vanmechelen E; Kapaki E; Verbeek M; Mollenhauer B
    Biomark Med; 2016; 10(1):19-34. PubMed ID: 26314196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo gastric detection of α-synuclein inclusions in Parkinson's disease.
    Sánchez-Ferro Á; Rábano A; Catalán MJ; Rodríguez-Valcárcel FC; Fernández Díez S; Herreros-Rodríguez J; García-Cobos E; Álvarez-Santullano MM; López-Manzanares L; Mosqueira AJ; Vela Desojo L; López-Lozano JJ; López-Valdés E; Sánchez-Sánchez R; Molina-Arjona JA
    Mov Disord; 2015 Apr; 30(4):517-24. PubMed ID: 25113060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
    Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
    Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease.
    Pouclet H; Lebouvier T; Coron E; Des Varannes SB; Neunlist M; Derkinderen P
    Neurogastroenterol Motil; 2012 Apr; 24(4):e202-5. PubMed ID: 22292943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
    Bougea A; Koros C; Stefanis L
    J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders.
    Gelpi E; Navarro-Otano J; Tolosa E; Gaig C; Compta Y; Rey MJ; Martí MJ; Hernández I; Valldeoriola F; Reñé R; Ribalta T
    Mov Disord; 2014 Jul; 29(8):1010-8. PubMed ID: 24395122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H; Sandmann-Keil D; Gai W; Braak E
    Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates.
    Resnikoff H; Metzger JM; Lopez M; Bondarenko V; Mejia A; Simmons HA; Emborg ME
    J Inflamm Res; 2019; 12():113-126. PubMed ID: 31123415
    [No Abstract]   [Full Text] [Related]  

  • 59. [Autonomic Dysfunction and Skin Biopsy in Dementia with Lewy Bodies].
    Orimo S
    Brain Nerve; 2018 Aug; 70(8):915-927. PubMed ID: 30082501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multi-Organ Distribution of Alpha-Synuclein Pathology in Dementia with Lewy Bodies].
    Wakabayashi K; Miki Y
    Brain Nerve; 2018 May; 70(5):489-500. PubMed ID: 29760287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.